Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
BACKGROUND: Zidovudine (AZT) monotherapy was the first antiretroviral drug to be tested widely. Subsequent trials in asymptomatic or early symptomatic HIV infection indicated short-term delays in disease progression with AZT, but not improved survival. OBJECTIVES: To assess the effects of immediate...
Main Authors: | Darbyshire, J, Foulkes, M, Peto, R, Duncan, W, Babiker, A, Collins, R, Hughes, M, Peto, T, Walker, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000) -
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000) -
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
by: Darbyshire, J, et al.
Published: (2000) -
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
by: Darbyshire, J, et al.
Published: (2000) -
Immediate versus deferred zidovudine.
by: Peto, R, et al.
Published: (1993)